Talis Biomedical Corporation
POLYNUCLEOTIDES FOR AMPLIFICATION AND DETECTION OF SARS-COV-2

Last updated:

Abstract:

Disclosed herein are primers and probes related to the detection of SARS-CoV-2 via nucleic acid amplification testing (NAAT), for example to amplify and determine the presence of SARS-CoV-2 in test samples and/or to diagnose Covid-19. Specifically, the present disclosure describes primers and probes that bind to the N gene, ORF1ab, or E gene of SARS-CoV-2 coronavirus for detection via loop mediated isothermal amplification (LAMP) and molecular beacon hybridization.

Status:
Application
Type:

Utility

Filling date:

20 May 2021

Issue date:

4 Nov 2021